Genetic predispositions in GLP-1 and GIPR pathways (measured by PlexusDx's Precision Peptide Genetic Test) may help provide context about your individual peptide-signaling phenotype, but genetics do not predict exact medication response
Contact your GP or prescribing clinician if you notice: Mood changes that feel disproportionate or unusual for you Irritability or emotional instability affecting relationships or work Anxiety that develops or worsens after starting treatment Sleep disturbances, particularly insomnia or excessive sleeping Symptoms of hypoglycaemia if you have diabetes (confusion, tremor, sweating, rapid heartbeat) Your healthcare provider can assess whether symptoms relate to the medication, underlying mental health conditions, or other factors
Cameron Smith
Skin Tone Customized Plans drip combinations are adjusted based on skin goals, lifestyle, and wellness needs
ESC 2025: post-hoc SURMOUNT-5 data affirms tirzepatides lead in CVD risk reduction Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
Your primary care physician can help you set realistic goals, support your journey and help you achieve sustainable changes
